Letermovir
Specifications
917389-32-3CAS Number
805-689-9EC Number
2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetic acidIUPAC Name
C29H28F4N4O4Chemical Formula
572.5 g/molMolecular Weight
Letermovir; 917389-32-3; Prevymis; AIC246; AIC-246; MK-8228; AIC 246; 1H09Y5WO1F; 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetic acid; DTXSID40238683; 2-((4S)-8-Fluoro-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3-(2-methoxy-5-(trifluoromethyl)phenyl)-4H-quinazolin-4-yl)acetic acid; 4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-(4-(3-methoxyphenyl)-1-piperazinyl)-3-(2-methoxy-5-(trifluoromethyl)phenyl)-, (4S)-; letermovirum; (4S)-2-(8-FLUORO-2-(4-(3-METHOXYPHENYL)PIPERAZIN-1-YL)-3-(2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL)-3,4-DIHYDROQUINAZOLIN-4-YL)ACETIC ACID; (4S)-2-{8-Fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazolin-4-yl}acetic acid; RefChem:57199; DTXCID90161174; J05AX18; 805-689-9; (S)-2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetic acid; MFCD22572725; Letermovir [INN]; Letermovir [USAN:INN]; UNII-1H09Y5WO1F; Prevymis (TN); (S)-[8-fluoro-2-[4-(3-methoxyphenyl)piperazine-1-yl]-3-(2-methoxy-5-trifluoromethylphenyl)-3,4-dihydroquinazoline-4-yl]acetic acid; (S)-{8-fluoro-2-[4-(3-methoxyphenyl)piperazine-1-yl]-3-(2-methoxy-5-trifluoromethylphenyl)-3,4-dihydroquinazoline-4-yl}acetic acid; Letermovir;4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-, (4S)-; (4S)-8-Fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4-quinazolineacetic acid; AIC 246; Letermovir; Prevymis; Letermovir (Standard); Letermovir(AIC246); LETERMOVIR [MI]; LETERMOVIR [JAN]; LETERMOVIR [USAN]; Letermovir(AIC-246)?; LETERMOVIR [WHO-DD]; Letermovir (JAN/USAN/INN); SCHEMBL379403; orb1220997; orb1301825; CHEMBL1241951; LETERMOVIR [ORANGE BOOK]; SCHEMBL29367234; SCHEMBL29438348; C29H28F4N4O4; EX-A1871; BDBM50614677; EBC-27337; HY-15233R; s8873; AKOS030526995; CS-1571; DB12070; NCGC00378936-01; NCGC00378936-02; 2-[(4S)-8-fluoro-3-[2-methoxy-5-(trifluoromethyl)phenyl]-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3,4-dihydroquinazolin-4-yl]acetic acid; AC-35698; AS-56206; DA-74962; FL104029; HY-15233; SY247494; NS00073296; T5396; D10801; D71052; EN300-18167086; F807098; BRD-K94288301-001-01-7; Q15409407; (S)-{8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-(2-methoxy-5-trifluoromethylphenyl)-3,4-dihydro-quinazolin-4-yl}acetic acid; (S)-{8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-(2-methoxy-5-trifluoromethylphenyl)-3,4-dihydroquinazolin-4-yl}acetic acid; (S)-2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-34-dihydroquinazolin-4-yl)acetic acid; {(4S)-8-Fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazolin-4-yl}acetic acid; Prevymis; AIC 246; (S)-2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetic acidSynonyms
Products Containing Letermovir
프레비미스주(레테르모비르)프레비미스정480밀리그램(레테르모비르)프레비미스정240밀리그램(레테르모비르)PREVYMIS 480 MG CONCENTRADO PARA SOLUCION PARA PERFUSIONPREVYMIS 240 MG CONCENTRADO PARA SOLUCION PARA PERFUSIONPREVYMIS 480 MG COMPRIMIDOS RECUBIERTOS CON PELICULAPREVYMIS 240 MG COMPRIMIDOS RECUBIERTOS CON PELICULAPREVYMIS 480 mg, solution à diluer pour perfusionPREVYMIS 480 mg, comprimé pelliculéPREVYMIS 240 mg, solution à diluer pour perfusionPREVYMIS 240 mg, comprimé pelliculéPREVYMIS 20 mg, granulés en sachet
Page 1 of 2
Companies Selling Letermovir
CP
CHENGHUI PHARMACEUTICAL GROUP LTDChinaYT
Yichang Tianrui Biopharm Co., Ltd.ChinaWH
Wuxi Hexia Chemical CompanyChinaNJ
Nantong Jinghua Pharmaceutical Co., Ltd.ChinaMS
MERCK SHARP & DOHMENetherlands한국
한국엠에스디(주)Republic of Korea